Mark S. Shearman

This profile gathers the share dealings of Mark S. Shearman across 2 companies, led by Applied Genetic Technologies Corp and Editas Medicine, Inc. Between 22 September 2016 and 13 February 2023, the trades on record add up to 10 filings.

On the open market, the record shows 2 purchases worth €24k and 3 sales worth €84k. Netting one side against the other leaves €60k of net selling. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 5 share grants. 2023 to date brings no purchases and 1 sale.

The newest entry dates from 15 February 2023: an open-market sale of €25k, in Editas Medicine, Inc. The last purchase on record was published on 26 September 2016, which is 3,680 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.